COPE-HCV: Continuous Interferon Delivery Via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV.
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2012
At a glance
- Drugs Interferon alpha-2b (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms COPE-HCV
- 23 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Jan 2011 Additional lead trial investigator (Sarah Mische) identified as reported by ClinicalTrials.gov.
- 20 Jan 2011 Planned end date changed from 1 Apr 2013 to 1 Jul 2012 as reported by ClinicalTrials.gov.